These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 558895

  • 1. Novel phenotypes arising from selection of hamster melanoma cells for resistance to BUdR.
    Kaufman ER, Davidson RL.
    Exp Cell Res; 1977 Jun; 107(1):15-24. PubMed ID: 558895
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Investigations of the mechanism of decreased tumorigenicity of cells grown in BrdU.
    Rothschild H, Black PH.
    J Cell Physiol; 1973 Apr; 81(2):217-24. PubMed ID: 4348555
    [No Abstract] [Full Text] [Related]

  • 5. Bromodeoxyuridine dependence--a new mutation in mammalian cells.
    Davidson RL, Bick MD.
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):138-42. PubMed ID: 4509645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Properties of 5-bromodeoxyuridine-resistant lines of higher plant cells in liquid culture.
    Ohyama K.
    Exp Cell Res; 1974 Nov; 89(1):31-8. PubMed ID: 4279827
    [No Abstract] [Full Text] [Related]

  • 11. 8-Azaguanine-resistant melanoma cells in vitro and in vivo.
    Pasztor LM, Hu F, Stankova L, Bigley R.
    J Natl Cancer Inst; 1974 Apr; 52(4):1143-50. PubMed ID: 4826585
    [No Abstract] [Full Text] [Related]

  • 12. The effects of controlled substitution of 5-bromodeoxyuridine (BUdR) for thymidine in hepatoma cell DNA.
    O'Brien JC, Stellwagen RH.
    Exp Cell Res; 1977 Jun; 107(1):119-25. PubMed ID: 16759
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.
    Silagi S, Balint RF, Gauri KK.
    Cancer Res; 1977 Sep; 37(9):3367-73. PubMed ID: 884681
    [No Abstract] [Full Text] [Related]

  • 16. Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
    Ashman CR, Kaufman ER, Davidson RL.
    Basic Life Sci; 1985 Sep; 31():391-408. PubMed ID: 3888181
    [No Abstract] [Full Text] [Related]

  • 17. Suppression of malignancy and differentiation in melanotic melanoma cells.
    Silagi S, Bruce SA.
    Proc Natl Acad Sci U S A; 1970 May; 66(1):72-8. PubMed ID: 4921328
    [Abstract] [Full Text] [Related]

  • 18. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL, Horn D.
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial thymidine kinase of bromodeoxyuridine-resistant, kinase-deficient HeLa(BU25) cells.
    Kit S, Kaplan LA, Leung WC, Trkula D.
    Biochem Biophys Res Commun; 1972 Dec 18; 49(6):1561-7. PubMed ID: 4639815
    [No Abstract] [Full Text] [Related]

  • 20. 5-Iodo-2-deoxyuridine resistance of vaccinia viruses in cells endowed with thymidine kinase activity.
    Marcialis MA, Biondi E, Atzeni A, Schivo ML, Uccheddu P, Loddo B.
    Experientia; 1973 Jun 15; 29(6):733-4. PubMed ID: 4268858
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.